NewGenIVF Group Ltd. logo

NewGenIVF Group Ltd. (NIVFW)

Market Closed
11 Jun, 20:00
NASDAQ (CM) NASDAQ (CM)
$
0. 02
-0
-4.2654%
Pre Market
$
0. 02
+0 +10.8911%
44.34K Market Cap
- P/E Ratio
- Div Yield
9,090 Volume
- Eps
$ 0.02
Previous Close
Investors:
Add Transaction
Day Range
0.02 0.03
Year Range
0.02 0.03
Want to track NIVFW and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

NIVFW closed today lower at $0.02, a decrease of -4.2654% from yesterday's close, completing a monthly increase of 23.9264% or $0. Over the past 12 months, NIVFW stock gained 18.1287%.
NIVFW is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on one exchange.

NIVFW Chart

People also search for

Estrella Immunopharma Inc.
$ 1.08
+1.8868%
Kalaris Therapeutics, Inc.
$ 4.72
+1.5054%
PolyPid Ltd.
$ 4.57
+1.3304%
Lantern Pharma Inc.
$ 4.07
+4.8969%
Eloxx Pharmaceuticals, Inc.
$ 12.64
+14.9091%

NewGenIVF Group Ltd. Investors

Name Quantity Cost Value Profit ($) Gain (%)
BO
Brian Oliveira Clear Street Group Inc.
389,270 $6,423.38 $7,785.4 $1,362.02 21.2%

NewGenIVF Group Ltd. (NIVFW) FAQ

What is the stock price today?

The current price is $0.02.

On which exchange is it traded?

NewGenIVF Group Ltd. is listed on NASDAQ (CM).

What is its stock symbol?

The ticker symbol is NIVFW.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 44.34K.

Has NewGenIVF Group Ltd. ever had a stock split?

No, there has never been a stock split.

NewGenIVF Group Ltd. Profile

Health Care Providers & Services Industry
Healthcare Sector
Wing Fung Siu CEO
NASDAQ (CM) Exchange
VGG0544E1135 ISIN
VG Country
76 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

NewGenIvf Group Limited operates as an investment holding company, dedicated to providing comprehensive assisted reproductive services. Founded in 2010 and headquartered in Bangkok, Thailand, the company extends its fertility treatments and related services to clients in multiple countries, including Thailand, Cambodia, Hong Kong, and Kyrgyzstan. Through its clinics, NewGenIvf Group Limited aims to support couples and individuals on their journey towards parenthood, offering a range of modern and effective fertility solutions accompanied by value-added services designed to improve the overall treatment experience.

Products and Services

  • In Vitro Fertilization (IVF) and ICSI

    Core services offered include the widely recognized IVF treatment, alongside Intracytoplasmic sperm injection (ICSI), a technique designed to enhance fertilization rates. These treatments represent foundational offerings in the company's suite of reproductive technologies.

  • Embryo Culture

    A critical step in the IVF process where embryos are carefully grown and observed in a laboratory setting to ensure their viability before being transferred to the uterus.

  • Hormonal Blood Tests and Infectious Diseases Tests

    Pre-treatment testing to assess the hormonal readiness of patients for the IVF process and to screen for any infectious diseases to ensure the health and safety of both the patients and the potential offspring.

  • Chromosome Screening

    Advanced genetic tests conducted to screen embryos for chromosomal abnormalities, which can significantly increase the chance of a successful pregnancy and healthy baby.

  • Hysteroscopy

    A procedure that allows doctors to look inside the uterus to diagnose and treat causes of abnormal bleeding. It’s also used to ensure the health of the uterine environment before embryo transfer.

  • Sperm Analysis, Sorting, Washing, and Freezing

    A comprehensive range of sperm preparation techniques that ensure the best sperm are selected for the fertilization process, and also include options for sperm preservation.

  • Egg Freezing

    A service that offers women the opportunity to freeze their eggs for use in future fertility treatments, providing flexibility and peace of mind for patients not yet ready to conceive.

  • IVF Treatment; Surrogacy and Ancillary Caring Services

    The company not only provides IVF treatment but also manages surrogacy arrangements, ensuring surrogate mothers receive comprehensive care, including health checks, vitamins, supplements, and necessary medications.

  • Value-Added Services

    Complementary services aimed at supporting the overall wellbeing of patients undergoing fertility treatments. This includes nutrition guidance, psychological counselling, acupuncture to improve treatment outcomes, and translation services for international clients to navigate the treatment process comfortably.

Contact Information

Address: PS Tower
Phone: 66 2 116 9641